Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Anupam Rasayan India Limited (ANURAS.NS)
INR1,267.80
+4.00 (+0.32%)
IN NSE Basic Materials Chemicals - Specialty
Address
8110, Sachin G.I.D.C. Estate 394230
Surat, IN
Surat, IN
CEO
Gopal Puranmal Agrawal
Website
anupamrasayan.com
IPO
2021-03-24
ISIN INE930P01018
Also trades on
Bombay Stock Exchange · ANURAS.BO (INR)
National Stock Exchange of India · ANURAS.NS (INR)
Description
Anupam Rasayan India Ltd., established in Surat, India, in 1984, specializes in the custom synthesis and production of specialty chemicals. The company manufactures a diverse range of life science-oriented chemicals, including intermediates and active ingredients crucial for the agrochemical sector, alongside compounds for antibacterial and ultraviolet protection applications in the personal care industry. Additionally, it provides essential intermediates and key starting materials vital for active pharmaceutical ingredients. Beyond these life science applications, Anupam Rasayan also supplies other specialized chemicals to various end-user segments, such as specialty pigments, dyes, and polymer additives. The company distributes its products both domestically and through exports.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
INR1,267.80
+4.00 (+0.32%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
309.7K
Beta
0.11
Float Shares
20.14M
Free Float %
17.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.06% | -0.12% | +2.18% | +9.48% | +11.24% | +3.90% | +38.27% | +12.34% | +77.41% | +160.12% | +160.12% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1,267.80
Ratings Trend (MoM)
43% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 4 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
3.38
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%+64.0% ★ Q1'26: +26.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+77.5% ★ Q1'26: -7.6% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+1.4% Q1'26: +51.7% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+16.3% ★ Q1'26: +14.9% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+5.5% Q1'26: +6.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+2.6% Q1'26: +3.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×3.56× Q1'26: 3.40× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 2 Rev. Ana. 2 EPS Ana. |
Mar 2027 4 Rev. Ana. 4 EPS Ana. |
Mar 2028 4 Rev. Ana. 4 EPS Ana. |
Mar 2029 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8.16B
est: 7.70B (+5.9%)
|
10.74B
est: 10.66B (+0.7%)
|
16.02B
est: 16.02B (+0.0%)
|
14.80B
est: 13.43B (+10.2%)
|
14.42B
est: 14.22B (+1.4%)
|
20.15B
18.97B – 21.32B
+41.7% YoY
|
24.27B
19.72B – 26.78B
+20.5% YoY
|
28.93B
22.78B – 33.16B
+19.2% YoY
|
28.50B
22.77B – 32.10B
-1.5% YoY
|
| EBITDA |
2.02B
est: 2.05B (-1.7%)
|
3.03B
est: 2.84B (+6.6%)
|
4.29B
est: 4.27B (+0.6%)
|
3.82B
est: 3.51B (+8.7%)
|
4.00B
est: 3.72B (+7.6%)
|
5.27B
4.96B – 5.58B
+41.7% YoY
|
6.35B
5.16B – 7.00B
+20.5% YoY
|
7.57B
5.96B – 8.67B
+19.2% YoY
|
7.45B
5.95B – 8.39B
-1.5% YoY
|
| EBIT |
1.52B
est: 1.63B (-6.6%)
|
2.45B
est: 2.26B (+8.5%)
|
3.61B
est: 3.39B (+6.3%)
|
3.07B
est: 2.78B (+10.5%)
|
3.05B
est: 2.94B (+3.5%)
|
4.17B
3.92B – 4.41B
+41.7% YoY
|
5.02B
4.08B – 5.54B
+20.5% YoY
|
5.99B
4.71B – 6.86B
+19.2% YoY
|
5.90B
4.71B – 6.64B
-1.5% YoY
|
| Net Income |
702.96M
est: 944.78M (-25.6%)
|
1.52B
est: 1.80B (-15.4%)
|
1.81B
est: 1.80B (+0.6%)
|
1.29B
est: 939.16M (+36.9%)
|
933.49M
est: 857.08M (+8.9%)
|
1.58B
1.56B – 1.61B
+84.8% YoY
|
2.34B
1.98B – 3.20B
+47.8% YoY
|
3.18B
2.75B – 4.20B
+35.8% YoY
|
5.12B
3.78B – 5.96B
+61.0% YoY
|
| SGA |
325.39M
est: 355.58M (-8.5%)
|
486.00M
est: 492.02M (-1.2%)
|
690.00M
est: 739.37M (-6.7%)
|
754.22M
est: 1.00B (-24.7%)
|
744.49M
est: 1.06B (-29.8%)
|
1.50B
1.42B – 1.59B
+41.7% YoY
|
1.81B
1.47B – 2.00B
+20.5% YoY
|
2.16B
1.70B – 2.47B
+19.2% YoY
|
2.13B
1.70B – 2.39B
-1.5% YoY
|
| EPS |
8.56
est: 8.60 (-0.5%)
|
15.22
est: 16.37 (-7.0%)
|
17.44
est: 18.54 (-5.9%)
|
11.89
est: 8.66 (+37.3%)
|
8.50
est: 7.99 (+6.4%)
|
14.05
13.80 – 14.30
+75.8% YoY
|
23.00
17.59 – 28.41
+63.7% YoY
|
30.80
24.36 – 37.24
+33.9% YoY
|
45.40
33.53 – 52.86
+47.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-25 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
4.33B
OE per share TTM
39.48
Owner's Yield
2.78%
Maintenance CapEx ratio
898.31%
Maint CapEx / Avg PPE
132.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 2 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree India Earnings Fund EPI | 0.05% | 1.11M | 0.84% |
| 2 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.03% | 236.0K | 0.65% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
2.03M
Shares Outstanding
113.85M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Anand Sureshbhai Desai | MD & Director | 38M | male |
| Mona Anandbhai Desai | Vice Chairman & Whole-Time Director | 38M | female |
| Anuj Hemantbhai Thakar | R&D (Process Development) Head & Whole-Time Executive Director | 12M | — |
| Jagdish Dongar Badhe | Senior General Manager of Operations | — | male |
| Nileshkumar Madhusudan Naik | Technical Head - Operations | — | — |
| Ujval Hemantkumar Vaishnav | President of Business Development | — | — |
| Amit Ajitbhai Khurana | Chief Financial Officer | — | male |
| Vishal Laxmikant Thakkar | Deputy Chief Financial Officer | — | male |
| Ashish Gupta | Company Secretary & Compliance Officer | — | male |
| Gopal Puranmal Agrawal | Chief Executive Officer | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ANURAS.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
